The Effect of Daily Intake of Selenium, Vitamin E and Folic Acid on Sperm Parameters in Males with Idiopathic Infertility: A Single-Blind Randomized Controlled Clinical Trial

Document Type : Original Article

Authors

1 Department of Midwifery, School of Nursing and Midwifery, Shiraz University of Medical Sciences, Shiraz, Iran

2 Department of Urology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran

3 Cardiovascular Research Center, Shiraz University of Medical Sciences, Shiraz, Iran

4 Department of Anatomy, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran

5 Embryology Department, Shiraz Fertility Center, Shiraz, Iran

Abstract

Background: Male infertility may originate from a wide spectrum of conditions while in 30-40 percent of cases, no significant
reason can be identified. Thereby, it is recognized as male idiopathic infertility. This study was undertaken to investigate
the effect of daily intake of selenium, vitamin E and folic acid on sperm parameters in males with idiopathic infertility.

Materials and Methods: Seventy infertile men were selected to participate in this single-blind, randomized controlled
clinical trial using convenience sampling. They were equally divided into two groups via permuted block
randomization method. The intervention group received selenium tablet (200 μg per day, oral), vitamin E capsule
(400 IU per day, oral) and folic acid tablet (5 mg per day, oral).The placebo group received matching placebo for
three months. Semen volume, total sperm motility, sperm concentration, progressive sperm motility, normal sperm
morphology, sperm motility index (SMI) and functional sperm concentration (FSC) were assessed by sperm quality
analyzer-v (SQAV) before and after the intervention. Paired t test, and independent t test were used to compare the
results within and between the groups, respectively. The IBM SPSS V.16.005 was used for data analysis. A p <0.05
was considered statistically significant.

Results: After three months, according to within-group analysis, a significant difference was found in mean SMI
(P=0.007) and FSC (P=0.001) in the intervention group. According to between-group analysis, no significant difference
was found in mean semen volume (P=0.610), sperm concentration (P=0.126), total sperm motility (P=0.765), progressive
sperm motility (P=0.767), normal sperm morph (P=0.403), SMI (P=0.556) or FSC (P=0.706) between the groups.

Conclusion: Consumption of selenium, vitamin E and folic acid in infertile men with asthenozoospermia was not effective
(Registration number: IRCT2017012432153N1).

Keywords


1.Vander Borght M, Wyns C. Fertility and infertility: definition and epi­demiology. Clin Biochem. 2018; 62: 2-10.
2.Haghighian HK, Haidari F, Mohammadi-Asl J, Dadfar M. Rand­omized, triple-blind, placebo-controlled clinical trial examining theeffects of alpha-lipoic acid supplement on the spermatogram andseminal oxidative stress in infertile men. Fertil Steril. 2015; 104(2):318-324.
3.Agarwal A, Mulgund A, Hamada A, Chyatte MR. A unique view onmale infertility around the globe. Reprod Biol Endocrinol. 2015;13: 37.
4.Katz DJ, Teloken P, Shoshany O. Male infertility - The other side ofthe equation. Aust Fam Physician. 2017; 46(9): 641-646.
5.Garg H, Kumar R. Empirical drug therapy for idiopathic male infer­tility: What is the new evidence? Urology. 2015; 86(6): 1065-1075.
6.Du Plessis SS, Agarwal A, Halabi J, Tvrda E. Contemporaryevidence on the physiological role of reactive oxygen speciesin human sperm function. J Assist Reprod Genet. 2015; 32(4):509-520.
7.Agarwal A, Parekh N, Selvam MKP, Henkel R, Shah R, Homa ST,et al. Male oxidative stress infertility (MOSI): proposed terminologyand clinical practice guidelines for management of idiopathic maleinfertility. World J Mens Health. 2019; 37(3): 296-312.
8.Alahmar AT. Role of oxidative stress in male infertility: an updatedreview. J Hum Reprod Sci. 2019; 12(1): 4-18.
9.Showell MG, Brown J, Yazdani A, Stankiewicz MT, Hart RJ. Anti­oxidants for male subfertility. Cochrane Database Syst Rev. 2011;19(1): Cd007411.
10.Henkel R, Sandhu IS, Agarwal A. The excessive use of antioxi­dant therapy: a possible cause of male infertility? Andrologia. 2019; 51(1): e13162.
11.Pieczynska J, Grajeta H. The role of selenium in human conception and pregnancy. J Trace Elem Med Biol. 2015; 29: 31-38.
12.Arcaniolo D, Favilla V, Tiscione D, Pisano F, Bozzini G, Creta M, etal. Is there a place for nutritional supplements in the treatment ofidiopathic male infertility? Arch Ital Urol Androl. 2014; 86(3): 164-170.
13.Ardestani Zadeh A, Arab D, Kia NS, Heshmati S, Amirkhalili SN.The role of vitamin E - selenium - folic acid supplementation inimproving sperm parameters after varicocelectomy: a randomized clinical trial. Urol J. 2019; 16(5): 495-500.
14.Magdi Y, Darwish E, Elbashir S, Majzoub A, Agarwal A. Effect ofmodifiable lifestyle factors and antioxidant treatment on semen pa­rameters of men with severe oligoasthenoteratozoospermia. An­drologia. 2017; 49(7): e12694.
15.Radwan M, Jurewicz J, Merecz-Kot D, Sobala W, Radwan P, Bo­chenek M, et al. Sperm DNA damage-the effect of stress and eve­ryday life factors. Int J Impot Res. 2016; 28(4): 148-154.
16.Ricci E, Vigano P, Cipriani S, Somigliana E, Chiaffarino F, BulfoniA, et al. Coffee and caffeine intake and male infertility: a systematic review. Nutr J. 2017; 16(1): 37.
17.Lammers J, Splingart C, Barriere P, Jean M, Freour T. Double-blind prospective study comparing two automated sperm analyzers versus manual semen assessment. J Assist Reprod Genet. 2014;31(1): 35-43.
18.Keskes-Ammar L, Feki-Chakroun N, Rebai T, Sahnoun Z, GhozziH, Hammami S, et al. Sperm oxidative stress and the effect of anoral vitamin E and selenium supplement on semen quality in infer­tile men. Arch Androl. 2003; 49(2): 83-94.
19.Scott R, MacPherson A, Yates RW, Hussain B, Dixon J. The effectof oral selenium supplementation on human sperm motility. Br JUrol. 1998; 82(1): 76-80.
20.Greco E, Romano S, Iacobelli M, Ferrero S, Baroni E, Minasi MG,et al. ICSI in cases of sperm DNA damage: beneficial effect of oralantioxidant treatment. Hum Reprod. 2005; 20(9): 2590-2594.
21.Eroglu M, Sahin S, Durukan B, Ozakpinar OB, Erdinc N, Turkgel­di L, et al. Blood serum and seminal plasma selenium, total an­tioxidant capacity and coenzyme q10 levels in relation to semenparameters in men with idiopathic infertility. Biol Trace Elem Res.2014; 159(1-3): 46-51.
22.ElSheikh MG, Hosny MB, Elshenoufy A, Elghamrawi H, Fayad A,Abdelrahman S. Combination of vitamin E and clomiphene citratein treating patients with idiopathic oligoasthenozoospermia: a pro­spective, randomized trial. Andrology. 2015; 3(5): 864-867.
23.Hassani-Bafrani H, Tavalaee M, Arbabian M, Dattilo M, Nasr-Esfa­hani MH. The effect of vitamin E & vitamin B on sperm function inrat varicocele model. Andrologia. 2019; 51(11): e13429.
24.Moslemi MK, Tavanbakhsh S. Selenium-vitamin E supplementa­tion in infertile men: effects on semen parameters and pregnancyrate. Int J Gen Med. 2011; 4: 99-104.
25.Hawkes WC, Alkan Z, Wong K. Selenium supplementation doesnot affect testicular selenium status or semen quality in NorthAmerican men. J Androl. 2009; 30(5): 525-533.
26.Irani M, Amirian M, Sadeghi R, Le Lez J, Latifnejad Roudsari R. Theeffect of folate and folate plus zinc supplementation on endocrine pa­rameters and sperm characteristics in sub-fertile men: a systematicreview and meta-analysis. Urol J. 2017; 14(5): 4069-4078.
27.Raigani M, Yaghmaei B, Amirjannti N, Lakpour N, Akhondi M, Zer­aati H, et al. The micronutrient supplements, zinc sulphate and folic acid, did not ameliorate sperm functional parameters in oligoasthe­noteratozoospermic men. Andrologia. 2014; 46(9): 956-962.
28.Mohammadi P, Hassani-Bafrani H, Tavalaee M, Dattilo M, Nasr-Esfa­hani MH. One-carbon cycle support rescues sperm damage in experi­mentally induced varicocoele in rats. BJU Int. 2018; 122(3): 480-489.
29.Ahmadi S, Bashiri R, Ghadiri-Anari A, Nadjarzadeh A. Antioxidantsupplements and semen parameters: An evidence based review.Int J Reprod Biomed. 2016; 14(12): 729-736.